Innovation Pharmaceuticals Inc (IPIX)

[frrol]

Not all. BP very likely wanted to see higher plasma concentrations and signs of disease response. This wasn't in the cards. But we got data on the MOA which is helpful. We will likely be doing the first oral K trial on our own. This is the same for B and P, and no big worry. But with a successful P P2b or a B deal, it will not require issuance.